pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4419b |
Genomic Coordinates | chr12: 128244506 - 128244573 |
Description | Homo sapiens miR-4419b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-4419b |
Sequence | 42| GAGGCUGAAGGAAGAUGG |59 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FBXW2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | FBW2, Fwd2, Md6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | F-box and WD repeat domain containing 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_012164 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on FBXW2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of FBXW2 (miRNA target sites are highlighted) |
>FBXW2|NM_012164|3'UTR 1 CACCATGAGCCACCACCGCTGACTGACTTTGGGTGCCGGGGCTGCGGGTTTTGGGTGCAACCTCTGCGGCAGCCGACTGC 81 ATGAACCAAAGTTCTCACCTAATGGTATCATCACGCAGTGCACAATCATTTATCTATGTTTTGCCAGGGGCCAGGGCTCG 161 GGGTGGGGGAGGGCTTGTTTTATTGACATACAACGCAGCATGCTAATGGGGTACACCATTGACTTCATTTGTACTTAGTT 241 ATGTTGGTCAGTGTTAGAGGATGCATTTTGGGTTCATCTTTCTTGAGTGGAGTATTGGTTTTAAGTAAAGAAAGTTAAAT 321 GATCCATTAATCTGCTAATTGGTTGCCTATGAAATCACATTGTCTGTTATTAAAGCTTTTTACCATAGCCTTTTTTTCTT 401 TTGAAGTTGAAGCAAAGGTGCTATGATGTTGTTACAGCAACTTTCCTCACACGGGGTTTAGCTCTTATAAGAGCCAGTGT 481 TAAAACTTCCACCAAATACCAGTTTATAAACTTCCACCAAATACCAGTGCTAAGGAAAGTCTGTCTTCCAGTTCAAATCC 561 AATTCTGTAAATTGAATGTTAGCAACTCATTCTAAACCTTATATCTTGGCAGAGTCAAGGTTGGCCATGTTTAAGATGTG 641 AGCGAGTTCTGTAGTTTTTGTTGCCATGTCGGGGAAGCTAGTCCCCGGCAGCCTGGATGACTGCACAGCGGTGCCCTGGT 721 ATAGCAGAAAAGAGCAGTGAGCTGGAAGGTTAGAGACCGGGCCTCTTACCCTGGAACTCTGCACCCTCTCTGGGTCCCAG 801 CTTCCTTGTCTGTACAGCCAGGTATGAAGCTCAGTGATTTCTAAGATTCTTTCTGGTCCTTCACCTACTGAAATGTGTAA 881 AAGTTGATCATGTATTTTTGTCTGATCCCTGATTCATGGTTTCTTTCAGGTCGGATAATATTTAAATGAAATGACTGTTA 961 CAGAGTTTTCTATAAGAACATCAATTATATGAAAAGGATGAATAAAAGGGAAATGTAGAAAATATAGCTGATTCCACTTA 1041 GACAGTTTAAGTAATTGGTTGAAGAAATGCTGATAGAAGCCATGGTTTAAATAGGGACACAGTATGCTATACTAGAAGGA 1121 TACCTGAACCCAACCTAACTTCCTCCTTTGCCTCTAACTTAATCTGCAGCCTCAGGCAAGTTAACTTTCTCTTCTAAGAC 1201 CATCATTTTCTTCATCTTTTAAGTGAGGGAATTGTCCTAGATGAGGGCTCACAAACCCAAATGCCTAAGGGAGCCGTGCA 1281 GGTAACATAAATGAGTAAAACATTCTGGGGAGGATTGTGCTGTCCCCTGGAAAGTTGATCTAATAGGGCAGTTATTCAGC 1361 TCTGTTTTGTCATTAGGAGAAGCAAGCCCAGGGTTGGCAGGTCTTCACATTGTTTCAGGAGGAGCTAGAAATCCAGATTT 1441 TTATTTGAAATCCTGGATTTTTAAAACGTTACAACTGATTAAAGAAAATTTGAAATAAGGTGAGCCAAACAAAACATGTC 1521 CCTGGGTTGCCAGATTGTGTCCTCCTCCCTCTCTAAAGTTAGGTAATTTTGTGATTCAGCAGTGGAAATGTTAGTGGTCA 1601 CAATCAGGGAGAGAGTAGAGGGAGCAAGCAGTAGAAAAATCTCAGCCGCTCTTCAGCTGTCTCCCCTTGTATTACAAGGG 1681 TGGTGGGGAGGGATGTATTTCATTCACAGACCAATAGGAAGGTAGTTTGAAGATGAACATAAGAATTGGAACCTCAGTGA 1761 CAGCTTATGTCTGGGAACATGAGTTATTCCTTCTTGCTGACTCCAGTATAAAGCATATCCATTTTACAGGTGAGAAAAAG 1841 GGTTGCTGGCAGAGCTGAGAATGATGTGAACTCTAGAGTGGGGACCTATCTCTTGCAGAATCTGCATTAGCATAGAGCCA 1921 GACTCTGGACCTCTGAGTGCTGTGAAGTTGATAGAAATTAATGGTGAATTTCAAGGACAGATATCATTAATATCCATGTT 2001 GAAACTCTGTGGGGTTTAAGCAAAAGAACAATATCTTCCCCCATCCCACAAAATCTGGGTTTAATCTATCTCACATTGAG 2081 TTCTGTGCATCAGCTCTGCTTAGTACTCTAGAAATAGAACCGGAATCACAACTGAATCTATTTTGCAGAAGCCCCAGGAG 2161 ACTTTGGGCAATGATGATGGTAAATGACTTTTTACTTTATTATTATTTTTTTTTTTTTGAGACAGAGTTTCGCTCTTACT 2241 GCGCAGGCTGGAGTGCAATGGCACGATCTTGGCTCACTGCAACCTCCGCCTCCTGGGTTCAAGTGATTCTCCTGCCTCAG 2321 CCTCCTAAGTAGCTGGGATTACAAGCATCTGCCATGACACCCAACTAATTTTTATATTTTTAGTAGAGACAGGGTTCCAC 2401 CATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAGGTCATCCACCTGCCTTGGCCTCCCAAAGTGCTGGGATTACAGG 2481 CGTGAGCCACCACGCCTGGCCGAGTTTTTACTTTTTATCGAGCCTGAACAGATAACTATTACTGATCTAATGACCATCCC 2561 CACCCTACCTCACTTTCAGATCTATCCAATAGCTTCAAAGGGCAAGTAATTATAATCATTTGTGGGAAAAGTTTTATTAA 2641 AAAGTGACAAACTTGAAGCTGTATATAGTATGTTCTATTTCAGTTTTTAGTGGTGAATACAGAAGTCATCAAGGTGGTAC 2721 TTGGTGCCGCTGGAATTTTTTTTTTTTCCTAGGCAGTCTTGCTCTGTCATACAGGCTGGAGTACAGTGGCATCATCATGC 2801 AGCTGGATTTTGACAGCAGAACTTCAGGCAGTAATTGGAGTCCTAATGTCAGTTCTTCCTTATGGAGGCCTTTATTTGGC 2881 CTGAGATTTTATTCAACTACTTTATAGATGCTGGGTTTATTCATACTATCGCCAGTTTTTATAAAAATGGAAAACTAGCT 2961 CATCCTTTTTGCAAAAGAAAGCAAAGTGGGGAGTCAGAATGAGAAGTGGATAGGGGATAACTAAAACTATTCTTTACTCT 3041 CCTTTCATTGCCTTTGAGAGCTAGCTCTTGCACACACTGACTTTGGCTTCCTTAGCGCATAGGTAAGGGAATTGCCTTTC 3121 CCTCTTTTGTGAATATTCTCATTTCTGAAAAATTCTAAGTCATGAGAAGATAAGCCCTATCCTTTCTTACAAGGATTGGA 3201 TTTCTTGGGTGACACTGTGGTGTGGTGGAAGCCAGCGGCTTCTTTCAGGTTCATAAAGGCCATCATAACAACTTCAGGCT 3281 TCATGGTGTGGACAGGGATCCAGGAGAGCTGAGTGGATGTGTGAAGTTTCTGATAGATTCTGTCATCATTCCAAAGGAAT 3361 GTAGTTTCCTCCAGCTCAATCATTTGAAGTAATACACATTGCCAAATCTGACTGTAACCTGACATTTTAGACCTATTGGA 3441 GAAATAGGAAGAAAGCCCCTCCAGTGGAAGGACTGGACTTGGAAGAAGTTCTGCAGGAAGGTGCATGCAATTGGATAGCT 3521 GTTCATGAGTGAAACGTGGGGAACATTGCTATGAAATTGTAAGGTTTGCACTTCATTTTTCGTAGTTTAAAAATTGCTCT 3601 GTTCTGGCTGTTGAAAACACTTGGTGTGAGGTTTGAATGAGGATTATATAATCATTCTAGTATTCATAGGAAAATGATTA 3681 CTGCTCTCTATTTGTAAAACAAAAGAAATAACTTTCGGAAACAGTATTTTAGACATGAGGAAATTGTTTGTATTAGGCAT 3761 TTTGATCTAACAGAATCAGCTAAGGATAGTGGATCCTGGCTTTACACATTTCTTTGACCAAACCCAGCTGGCAACTTGAA 3841 GTTGTTACTGTGTGGCTTCCAGATTGCCTAGAGGTGAATCCTACCAACATCACTGTTTTTTTTGTTTTGTTTTGTTTTTT 3921 TTGTATGTTTTTGAGACAGAGTCTTGCTCTATCCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTTACTGCAACCTCAG 4001 CCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGAGACTACAGGCGCGTGCCACCACGCCCAGCTAT 4081 TTTTGTATTTTTAGTAGAGACGAGGTTTCACTATGTTGGCCAGGATGGTCTTGATTTCTTGACCTCGTGTTCTGCCCGCC 4161 TCTACCTCCCAAAGTGCCGGGATTACAGGCGTGAGCTGCTGTGCCCGGCCCCAGCATCACTTTTATAGCTTTCTGTGCCT 4241 CTTCCTCTGGGCCTTGGTGTATGAAGCCACTTGCCTTTCTCTGTTGGGAAGCGAGCAGAATCAGATTGCTACTCATGATG 4321 CAGTCCGGGCAGGGCATACTGTCACCTTTGCCTGTGGACACAGTTGTCAGGATAGGGGAGAAGCCCTTTAGGTCCGTCTT 4401 CTTGACACAGCCCTCCTACCTGGTTACGCTGGTGCTTTCGCTTGGTTTAGACAACCAAGACACTTGAGAATTATGCTGTC 4481 CTCAGAATGTCTGATGAAAAGAACAGATTCACTTTTTTGACACAATGCCCATTAGCCATCTTTGGCAGTGTTTCTGATCA 4561 AAGGTTCCCCATGCCTGCTCTAGGAAAGTAAACTTTTTTCAGAATAAATCCTCAAATGGATTACTGAGTAGTCTTTGCAC 4641 CATTCCCATCAGCCTAATCAGACTGAATGGTCACGCTCAGTGCAAAAAGCTGTTTTGCTGTTAGGATGTTTCAGTGTTTC 4721 TTGTCTTTCCTGGAACAGTTCAGTTGTTTAAATTTAGTAATTCAATCCTGACCAGTGTAAACCCACTTAATTATTGCAGC 4801 CTAAAGAATTCAGCTACTTCTACTCTTCATAAATGTGCCCAAGTAAATATGTGTTTTTAATATTCAACCCTGGAAAATTA 4881 GTAATTCAGATGATAAAAGCTCATGTTTTGGTGTCTTTGTACTCAGATTGTGAACAGGCATATTTCACTGATTTAGACTT 4961 AGTATACTTGATGAGAATGCTCAGGTTGAAGAGATAGTTCTGTCAGCAATCCAACATCTATAGCAATGTGGAAAAAGTAA 5041 TCAACTCATATTTCACGAATTTGATGTATGTTGTGATTTAGAGGGCATGAGATAAAGTTTATATTTGAACTGTGTGGGGT 5121 AGGGGGAAGAAGAGGTTGCTTAAGCAAATAGTGGGGTGATTGTGGAACAAGATGTCTCTAAGATGAGAAGTTATTTTCTT 5201 GCATCATAGAAGCACTCTTTTTACCCGTGAGTGATTGTGTTAACTATAAATCATTTATATCTGTACATTAAAGCAGATTC 5281 CCTCAATTAGGCAAATTTGGTTAGCCAAGCCCAAGTTATTGTTTGTACTTGAAAGTAATAAAGCTGCATTTCCTTAAAAA 5361 TATATTCTGTAGTTAAGACTTTGTCTTGCTTTCCCCCCAACCACTTCAGACATTTTATCCAACCAATGCAGGGACTTTTC 5441 AAAAGTCAGTGTGTTTTTGAAAATAGAACAACCCCTTGAGTGATCTGAGGTGGCTCTGTTTTTTTACTGTTTCTGCATCT 5521 TCTAGAAGGTAAACTCAACAATATAACCATTTCTGAAGGTGATCCAAAAAGCAAAACAATAAAGGTAAAACACAAGGAAA 5601 TAATTTTGGTGAATTTCATGAATAGTTGCAAATGAAGGGATGGGGTGGGTAAAAGTCCCATTTTGCTTCCAGACCTTGGA 5681 ATAGTCTTCCTCTCTTTTGCCCAAGGATGTGTCTATCCAGCACATCTTTGCATGAGTTCTTTCTTACTAACTTAAACTTA 5761 CGGGGCTTCTTGTCATTTGAGTACCACGGCCCTGCACCTTTGATCCCCTGACAGCATCATTAAGGGCAGATTGTCATTCC 5841 TGTTTTACAGATGAGAAAGCTGTGGCTTGGTAAAGTGATTCATTGCCTAGAGGAGTTATAGTAAGTGGTGAGGCTGAAGC 5921 CCTGATTTTCAGCCCCCACACACCTGGATTTTTTCCATGTTTTCATGTTTGTCTGTTCTTTCTGTATTTCAAGTCTCTTC 6001 AAATCCCGACTGCTGCCTTCTGCCTTCACCACTTGTGTGCACTGTTCAACCTGTCTTATGCTTTGCTTCCAGGGAGTCTC 6081 CCCAACCACTTCTTTGAGCACTTACTTGCTCTTGTTCAATCTTGGTAACTCTCCGTTACCATCAGGGCACATCTGGATTC 6161 CTTAACATCATGGAGCCCTAGCTAATTTCTTCGAGCAAACAGTTCTTGCTCCTCTATTTATTTCCACCCTTGCGCTTTGG 6241 GTGTTAATCTCCCATCCTCGTGGAAAGTTCTTGATGTTCCTTTCCACCAGTCCTAGGGCCAGGCTTTAATCCCATTGATC 6321 TCCCACTATCTTTAAAGCCTCTGCTGACCACCATACCCCACTCCAGCCTCACTGAGCATTTTTGTGTAAGGTTAGTGGTG 6401 CAGTTCATTTAGCAATAAATACTGTTGTACCTTTTGCAGTAGACAACTATTAACTTTCATCCTTGATTCTCAGTTTTTTC 6481 CAAAATACAAGTGAATACCTGGTTTCCCCAGCAACATTGTAAGATTGAGAGTAGGAATTCATTGAGATTTTAATGAATTC 6561 CATGGATTGTCTTAAGAGCTATCTAAACTTGGAAGAAAAATAACTTCCAGAGCATCTAAAATTGAAAATAAAAGATCAGA 6641 AGCAAATGAAAGATCAATTCCACACAGCTTTTCCTCTCTTAGACGTCCCTCTTCTGCCATATCCTGTAAACATCTGAAGT 6721 GTTCTGAGTACATTTGGAGAGAATATTTAATGATCACACTGTGATTAGACATGAGTAGTCCCTGCCAGTGGGATGTTCCT 6801 GTCCTTTGCATTTTAACCACATGTTCTGTGCTCTCTGTGGTAAAGATAATCTAACAGTAATAAAAACTTATGGAGAAAAT 6881 TACCCAGAGCTCCTTTATCATTACGATTTTTAATACTCTCTTCTAATCCTTATGCACATGTGTATGGATTTATGTACTGC 6961 AAATCATTGTTTTGTAATACATTCTCAAAAATGTGCTTTAGGTTTTTACAACTACCATAATATTTTGTAATTTTCCTTCA 7041 TTACTGTAATTTGCTAAACCATTTCTGTTTTGGTAGATAATTAGGTAGTTTCCAGTTCTGCTTTTTAGAAGATACTACAG 7121 AGAACTTCTTTGTGCATATTTCCTTAGAACAAGTTCCAGTAGAAGACTTACTCGCAAAAGCAGTGGAATTTTTTCTTAGT 7201 ATTTTCTGTTACAGGTACAGAAGAGTGCATACAACACACAGTTTTGTCGAATAGTTATGAAGTGAACACTTGTCTAACCA 7281 CTGCCCGAGTCAAGAAAGAACATTTCTAAACATGTTTGCCAATTTAATAGATATAAAGGAAGTATCTCAAGGTTGCTTTA 7361 ACTGACATTTCTTTAACACATGACAACATTTTTATGGGGGAGGGGACTAGAGAGAAAATGACATATTTTTATGTGTGCTT 7441 ATTTGTATCTCTTGAATTCTGTCTGCATCTTTTACCCATTACACTTTCAAATACTTGTGAAATCATTGGTCGAGATGAAT 7521 TATGGCTATAAATAAAATTTCACTAATCTAATTATCACTGATTTAGAAATAATAGTTCAACCC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_012164 | 3UTR | CUGCAACCUCCGCCUCCUGGGUUCAAGUGAUUCUCCUGCCUCAGCCUCCUAAGUAGCUGGGAUUACAAGCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_012164 | 3UTR | UACUGAGUAGUCUUUGCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_012164 | 3UTR | AUGGAUUACUGAGUAGUCUUUGCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_012164 | 3UTR | GCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_012164 | 3UTR | CAGAAUAAAUCCUCAAAUGGAUUACUGAGUAGUCUUUGCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_012164 | 3UTR | UGGAUUACUGAGUAGUCUUUGCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_012164 | 3UTR | AAAUGGAUUACUGAGUAGUCUUUGCACCAUUCCCAUCAGCCUAAUCAGACUGAAUGGUCACGCUCAGUGCAAAAAGCUGUUUUGCUGUUAGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000608872.1 | 3UTR | CUCAGCCUCCUGGGUUCAAGCGAUUCUCCUGCCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
390 hsa-miR-4419b Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT061343 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 4 | ||||||
MIRT072743 | GLCE | glucuronic acid epimerase | ![]() |
![]() |
2 | 2 | ||||||
MIRT180549 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT186147 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT271044 | PGAM5 | PGAM family member 5, mitochondrial serine/threonine protein phosphatase | ![]() |
![]() |
2 | 4 | ||||||
MIRT334761 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | ![]() |
![]() |
2 | 6 | ||||||
MIRT443279 | TSPAN15 | tetraspanin 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447047 | ZNF439 | zinc finger protein 439 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447351 | KIF6 | kinesin family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448925 | CKS1B | CDC28 protein kinase regulatory subunit 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT452899 | PSD4 | pleckstrin and Sec7 domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453087 | SUMF2 | sulfatase modifying factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454071 | SLC35E3 | solute carrier family 35 member E3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456216 | LIX1L | limb and CNS expressed 1 like | ![]() |
![]() |
2 | 6 | ||||||
MIRT456951 | LRP10 | LDL receptor related protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458025 | MRPL12 | mitochondrial ribosomal protein L12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459999 | RFT1 | RFT1 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT460046 | CDCP1 | CUB domain containing protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460982 | STK17B | serine/threonine kinase 17b | ![]() |
![]() |
2 | 2 | ||||||
MIRT464405 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466256 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466536 | TBXA2R | thromboxane A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT470922 | PLD5 | phospholipase D family member 5 | ![]() |
![]() |
2 | 8 | ||||||
MIRT472835 | MTMR10 | myotubularin related protein 10 | ![]() |
![]() |
2 | 6 | ||||||
MIRT473352 | MEMO1 | mediator of cell motility 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475504 | HSP90B1 | heat shock protein 90 beta family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478862 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480898 | BCL9L | B-cell CLL/lymphoma 9 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT482686 | NXN | nucleoredoxin | ![]() |
![]() |
2 | 4 | ||||||
MIRT484128 | C14orf142 | GON7, KEOPS complex subunit homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT486172 | TLE3 | transducin like enhancer of split 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT486539 | CLCN7 | chloride voltage-gated channel 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT486588 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495475 | ALDOA | aldolase, fructose-bisphosphate A | ![]() |
![]() |
2 | 2 | ||||||
MIRT495536 | TXNRD2 | thioredoxin reductase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495566 | UNC5C | unc-5 netrin receptor C | ![]() |
![]() |
2 | 2 | ||||||
MIRT495719 | PADI1 | peptidyl arginine deiminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495890 | CLOCK | clock circadian regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT495932 | SLC7A5P2 | solute carrier family 7 member 5 pseudogene 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496026 | ZBED3 | zinc finger BED-type containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496216 | PAX6 | paired box 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496349 | VAMP1 | vesicle associated membrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496354 | PPY | pancreatic polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT496400 | ZSCAN16 | zinc finger and SCAN domain containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496416 | PARVB | parvin beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT496458 | N6AMT1 | N-6 adenine-specific DNA methyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496519 | GINS2 | GINS complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496562 | SLC39A9 | solute carrier family 39 member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498605 | KRT8 | keratin 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503434 | SLC25A45 | solute carrier family 25 member 45 | ![]() |
![]() |
2 | 6 | ||||||
MIRT503573 | AGAP9 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503847 | ATP13A4 | ATPase 13A4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504247 | LHPP | phospholysine phosphohistidine inorganic pyrophosphate phosphatase | ![]() |
![]() |
2 | 4 | ||||||
MIRT505606 | SLC35F1 | solute carrier family 35 member F1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507749 | CERS2 | ceramide synthase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT508411 | C1orf210 | chromosome 1 open reading frame 210 | ![]() |
![]() |
2 | 6 | ||||||
MIRT508508 | RSRC1 | arginine and serine rich coiled-coil 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT508944 | AK4 | adenylate kinase 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT509460 | ZNF587 | zinc finger protein 587 | ![]() |
![]() |
2 | 6 | ||||||
MIRT509862 | ZNF641 | zinc finger protein 641 | ![]() |
![]() |
2 | 4 | ||||||
MIRT511397 | IKZF3 | IKAROS family zinc finger 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512517 | BTBD19 | BTB domain containing 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513507 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | ![]() |
![]() |
2 | 6 | ||||||
MIRT514155 | TMEM145 | transmembrane protein 145 | ![]() |
![]() |
2 | 4 | ||||||
MIRT514486 | SLPI | secretory leukocyte peptidase inhibitor | ![]() |
![]() |
2 | 4 | ||||||
MIRT514521 | SHISA9 | shisa family member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT514970 | KLLN | killin, p53-regulated DNA replication inhibitor | ![]() |
![]() |
2 | 4 | ||||||
MIRT515030 | IRAK4 | interleukin 1 receptor associated kinase 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT515963 | C9orf156 | tRNA methyltransferase O | ![]() |
![]() |
2 | 2 | ||||||
MIRT516092 | ZBTB8OS | zinc finger and BTB domain containing 8 opposite strand | ![]() |
![]() |
2 | 4 | ||||||
MIRT517223 | PRIM1 | DNA primase subunit 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT517459 | PEX26 | peroxisomal biogenesis factor 26 | ![]() |
![]() |
2 | 4 | ||||||
MIRT517790 | EFCAB11 | EF-hand calcium binding domain 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517979 | DSCR3 | DSCR3 arrestin fold containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT519458 | CSTF1 | cleavage stimulation factor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519599 | ZNF805 | zinc finger protein 805 | ![]() |
![]() |
2 | 2 | ||||||
MIRT520339 | UBXN2A | UBX domain protein 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT521345 | RPP14 | ribonuclease P/MRP subunit p14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521571 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | ![]() |
1 | 1 | |||||||
MIRT523382 | GSG2 | histone H3 associated protein kinase | ![]() |
![]() |
2 | 8 | ||||||
MIRT524106 | DNA2 | DNA replication helicase/nuclease 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT524886 | ARHGAP11A | Rho GTPase activating protein 11A | ![]() |
![]() |
2 | 4 | ||||||
MIRT528772 | CD1D | CD1d molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT530665 | TRIM56 | tripartite motif containing 56 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531107 | PEX13 | peroxisomal biogenesis factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531575 | ILDR1 | immunoglobulin like domain containing receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535173 | PLEKHB2 | pleckstrin homology domain containing B2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT544168 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | ![]() |
![]() |
2 | 2 | ||||||
MIRT550582 | SLC2A5 | solute carrier family 2 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551039 | GDE1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT551295 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT551339 | MRE11A | MRE11 homolog, double strand break repair nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT552092 | SLFN12L | schlafen family member 12 like | ![]() |
![]() |
2 | 6 | ||||||
MIRT555403 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | ![]() |
![]() |
2 | 2 | ||||||
MIRT557087 | HOXB3 | homeobox B3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559388 | ATP11C | ATPase phospholipid transporting 11C | ![]() |
![]() |
2 | 2 | ||||||
MIRT560305 | DFFA | DNA fragmentation factor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT561028 | LIN7C | lin-7 homolog C, crumbs cell polarity complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT562460 | COX6B1 | cytochrome c oxidase subunit 6B1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT562982 | PARK7 | Parkinsonism associated deglycase | ![]() |
![]() |
2 | 2 | ||||||
MIRT563548 | PMPCA | peptidase, mitochondrial processing alpha subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT564412 | EMILIN2 | elastin microfibril interfacer 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT569437 | PCGF3 | polycomb group ring finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572097 | EXOC8 | exocyst complex component 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575571 | Cd99 | CD99 antigen | ![]() |
![]() |
2 | 2 | ||||||
MIRT575789 | Tnfrsf10b | tumor necrosis factor receptor superfamily, member 10b | ![]() |
![]() |
2 | 2 | ||||||
MIRT576975 | Lmtk2 | lemur tyrosine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT610864 | ARSA | arylsulfatase A | ![]() |
![]() |
2 | 2 | ||||||
MIRT614061 | NTPCR | nucleoside-triphosphatase, cancer-related | ![]() |
![]() |
2 | 2 | ||||||
MIRT614141 | THAP1 | THAP domain containing 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT615235 | BROX | BRO1 domain and CAAX motif containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT617429 | ANP32E | acidic nuclear phosphoprotein 32 family member E | ![]() |
![]() |
2 | 4 | ||||||
MIRT618882 | MBL2 | mannose binding lectin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618984 | MRPS16 | mitochondrial ribosomal protein S16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619196 | SLC16A4 | solute carrier family 16 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT620323 | AQP6 | aquaporin 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621960 | STX7 | syntaxin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622057 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624930 | FBXW2 | F-box and WD repeat domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624986 | ZNF665 | zinc finger protein 665 | ![]() |
![]() |
2 | 4 | ||||||
MIRT625463 | ZNF681 | zinc finger protein 681 | ![]() |
![]() |
2 | 4 | ||||||
MIRT625497 | SMAD9 | SMAD family member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625599 | KLHL23 | kelch like family member 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625668 | C2orf48 | chromosome 2 open reading frame 48 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625888 | INADL | PATJ, crumbs cell polarity complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT626161 | NFYA | nuclear transcription factor Y subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT626238 | ZNF749 | zinc finger protein 749 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626631 | SLC30A6 | solute carrier family 30 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626994 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627898 | OLFML2A | olfactomedin like 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT627988 | NDRG3 | NDRG family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628324 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | ![]() |
![]() |
2 | 2 | ||||||
MIRT628549 | ZNF701 | zinc finger protein 701 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629464 | WIZ | widely interspaced zinc finger motifs | ![]() |
![]() |
2 | 2 | ||||||
MIRT630527 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT631487 | KLHL21 | kelch like family member 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT631957 | CDKAL1 | CDK5 regulatory subunit associated protein 1 like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT632178 | CCL22 | C-C motif chemokine ligand 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632282 | TVP23C | trans-golgi network vesicle protein 23 homolog C | ![]() |
![]() |
2 | 2 | ||||||
MIRT632321 | TMEM185B | transmembrane protein 185B | ![]() |
![]() |
2 | 2 | ||||||
MIRT632853 | IGF1 | insulin like growth factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632862 | HSPA2 | heat shock protein family A (Hsp70) member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633322 | LINC00346 | long intergenic non-protein coding RNA 346 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633398 | FBXW8 | F-box and WD repeat domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633930 | DNAH9 | dynein axonemal heavy chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634785 | CBFA2T2 | CBFA2/RUNX1 translocation partner 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634851 | ABCF1 | ATP binding cassette subfamily F member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636370 | OGFRL1 | opioid growth factor receptor like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637219 | TRUB2 | TruB pseudouridine synthase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637690 | PPM1D | protein phosphatase, Mg2+/Mn2+ dependent 1D | ![]() |
![]() |
2 | 2 | ||||||
MIRT639196 | TRAPPC2 | trafficking protein particle complex 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639599 | CD3EAP | CD3e molecule associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT639681 | PPEF2 | protein phosphatase with EF-hand domain 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT640669 | ARSK | arylsulfatase family member K | ![]() |
![]() |
2 | 2 | ||||||
MIRT642377 | ZNF581 | zinc finger protein 581 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642403 | ZNF556 | zinc finger protein 556 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645079 | UQCRQ | ubiquinol-cytochrome c reductase complex III subunit VII | ![]() |
![]() |
2 | 2 | ||||||
MIRT646475 | ZNF669 | zinc finger protein 669 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647325 | RPH3AL | rabphilin 3A like (without C2 domains) | ![]() |
![]() |
2 | 2 | ||||||
MIRT647490 | ZNF639 | zinc finger protein 639 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647989 | PDE12 | phosphodiesterase 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648196 | CENPN | centromere protein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT649006 | MRPL49 | mitochondrial ribosomal protein L49 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650457 | ZNF141 | zinc finger protein 141 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650533 | CCDC77 | coiled-coil domain containing 77 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650999 | ZNF770 | zinc finger protein 770 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653832 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT655734 | NRXN3 | neurexin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657577 | GRSF1 | G-rich RNA sequence binding factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658610 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658633 | ENAH | ENAH, actin regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT659820 | CASP16 | caspase 16, pseudogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT661142 | ZNF43 | zinc finger protein 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661201 | MPPE1 | metallophosphoesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661436 | MANSC1 | MANSC domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661498 | CHMP1B | charged multivesicular body protein 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT661682 | ZNF623 | zinc finger protein 623 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661796 | NLRC3 | NLR family CARD domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661808 | NUP85 | nucleoporin 85 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661861 | ZNF766 | zinc finger protein 766 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661889 | EXOSC6 | exosome component 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662291 | SLC29A4 | solute carrier family 29 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662515 | ANGPT4 | angiopoietin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662682 | LRRC47 | leucine rich repeat containing 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662716 | C10orf111 | chromosome 10 open reading frame 111 | ![]() |
![]() |
2 | 4 | ||||||
MIRT662834 | LY6G5B | lymphocyte antigen 6 family member G5B | ![]() |
![]() |
2 | 2 | ||||||
MIRT662890 | PCDHA6 | protocadherin alpha 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663134 | ULBP3 | UL16 binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663710 | ABHD17B | abhydrolase domain containing 17B | ![]() |
![]() |
2 | 2 | ||||||
MIRT663869 | MUC20 | mucin 20, cell surface associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT664267 | NMUR1 | neuromedin U receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664510 | POLR3K | RNA polymerase III subunit K | ![]() |
![]() |
2 | 2 | ||||||
MIRT664659 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664849 | HUS1 | HUS1 checkpoint clamp component | ![]() |
![]() |
2 | 2 | ||||||
MIRT664944 | CARD6 | caspase recruitment domain family member 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT665348 | YES1 | YES proto-oncogene 1, Src family tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT665514 | UTP15 | UTP15, small subunit processome component | ![]() |
![]() |
2 | 2 | ||||||
MIRT665648 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665668 | TRAF1 | TNF receptor associated factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665692 | TNPO3 | transportin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665741 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665850 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665940 | TBC1D19 | TBC1 domain family member 19 | ![]() |
![]() |
2 | 4 | ||||||
MIRT666005 | SYNJ2BP | synaptojanin 2 binding protein |